WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Alcohol tx, Alcohol treatment relapse prevention, Naltrexone effectivness? FDA approved, Pharmacological Naltrexone, -In ICU -small dose of antipsychotic eg Haloperidol -BDZs could be tried (usually non-beneficial once DT begins) BDZs, relapse prevention Non-pharmacological, withdrawal support medical conditions vitamin deficiency, Disulfiram mechanism -accumulation of acetaldehyde (inhibit acetaldehyde dehydrogensase) leading to facial flushing, N,V, BP changes., Non-pharmacological Motivational Enhancement Treatment (MET), withdrawal support medical conditions pancreas, BDZs Which? In liver impairment Lorazepam, Oxazepam., withdrawal Pharmacological BDZs, withdrawal support medical conditions liver, Acamprosate effectivness? FDA approved for alcohol dependence, Alcohol treatment withdrawal, withdrawal support medical conditions infections, According to project MATCH (Matching Alcoholism treatments w/ client heterogeneity). Pt.s w/less anger, vitamin deficiency Folic acid Thiamine (before glucose): 100 mg IM inj daily x3days then 100 mg tab po daily x3days to avoid Wernicke-Korsakoff synd., Naltrexone effectivness? monthly injections available, BDZs Which? Those w/longer half life, to avoid frequent troughs and peaks of serum level., -usually self-limited -supportive Tx. -BDZs. BDZs